 Fulcrum Therapeutics, Inc. FULC today announced the closing of a 68.5 million private placement pursuant to a securities purchase agreement with a group of institutional investors and accredited investors. The private placement includes a mix of new and existing investors, including EcoR1 Capital, LLC, Alyeska Investment Group, L.P., Boxer Capital, Casdin Capital LLC, Perceptive Advisors LLC, Samsara BioCapital, Monashee Investment Management LLC and Foresite Capital. SVB Leerink acted as the exclusive placement agent to the Company in connection with the private placement. 